The pathologist's role in sentinel lymph node evaluation

Cochran AJ, Morton DL, Wen D-R: The Surgical Pathology of dye-directed selective lymph node dissection, in Nieweg OE, Essner R, Reintgen DS (eds): Lymphatic Mapping. Marcel Dekker, New York. (in press). Cochran, 1999, Surgical pathology remains pivotal in the evaluation of “sentinel” lymph nodes, Am J Surg Pathol, 23, 1169, 10.1097/00000478-199910000-00001 Goldsmith, 1970, Prognostic significance of lymph node dissection in the treatment of malignant melanoma, Cancer, 26, 606, 10.1002/1097-0142(197009)26:3<606::AID-CNCR2820260317>3.0.CO;2-M Day, 1982, Prognostic factors for patients with clinical Stage I melanoma of intermediate thickness (1.5-3.99 mm), Ann Surg, 195, 35, 10.1097/00000658-198201001-00006 Balch, 1988, The role of elective lymph node dissection in melanoma: Rational, results and controversies, J Clin Oncol, 6, 163, 10.1200/JCO.1988.6.1.163 Balch, 1996, Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger, Ann Surg, 224, 255, 10.1097/00000658-199609000-00002 Cochran, 1988, Occult tumor cells in the lymph nodes of patients with pathological Stage I malignant melanoma: An immunohistological study, Am J Surg Pathol, 12, 612, 10.1097/00000478-198808000-00002 Veronesi, 1977, Inefficacy of immediate node dissection in Stage I melanoma of the limbs, N Engl J Med, 297, 627, 10.1056/NEJM197709222971202 Veronesi, 1982, Delayed regional lymph node dissection in Stage I melanoma of the skin of the lower extremities, Cancer, 49, 2420, 10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2 Sim, 1978, A prospective, randomized study of the efficacy of routine elective lymphadenectomy in the management of melanoma, Cancer, 41, 948, 10.1002/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z Cady, 1988, “Prophylactic” lymph node dissection on melanoma: Does it help?, J Clin Oncol, 6, 2, 10.1200/JCO.1988.6.1.2 Coats, 1995, Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991, J Am Coll Surg, 180, 402 Moore, 1965, Chemistry and biology of two proteins, S-100 and 14-3-2, specific to the nervous system, Biochem Biophys Res Commun, 19, 739, 10.1016/0006-291X(65)90320-7 Gaynor, 1980, S-100 protein in cultured human malignant melanomas, Nature, 286, 400, 10.1038/286400a0 Gaynor, 1981, S-100 protein: A marker for human malignant melanomas?, Lancet, 1, 869, 10.1016/S0140-6736(81)92142-5 Cochran, 1982, Detection of S-100 protein as an aid to the identification of melanocytic tumors, Int J Cancer, 30, 295, 10.1002/ijc.2910300307 Cochran, 1983, Detection of S-100 protein in the diagnosis of primary and metastatic intraocular tumors, Invest Ophthalmol Vis Sci, 24, 1153 Wen, 1983, S-100 protein: A marker for melanocytic tumors, Ann NY Acad Sci, 420, 261, 10.1111/j.1749-6632.1983.tb22211.x Wen, 1983, S-100 protein: A marker for melanocytic tumors, Ann NY Acad Sci, 420, 261, 10.1111/j.1749-6632.1983.tb22211.x Gown, 1986, Monoclonal antibodies specific for melanocyte tumors distinguished subpopulations of melanocytes, Am J Pathol, 123, 195 Chen, 1996, Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogenously expressed in human melanomas, 93, 5915 Fetsch, 1997, Immunocytochemical detections of MART-1 in fresh and paraffin embedded malignant melanomas, J Immunother, 20, 60, 10.1097/00002371-199701000-00006 Hagen, 1986, Correlation of histopathological characteristics with staining patterns in human malignant melanoma assessed by (monoclonal) antibodies reactive on paraffin sections, Histopathology, 10, 689, 10.1111/j.1365-2559.1986.tb02522.x Cochran, 1984, Occult melanoma in lymph nodes detected by antiserum to S-100 protein, Int J Cancer, 34, 159, 10.1002/ijc.2910340204 Cochran, 1987, Zoned immune suppression of lymph nodes draining malignant melanoma: Histologic and immunohistologic studies, J Natl Cancer Inst, 78, 399 Hoon, 1987, Variations in functional immunocompetence of human tumor-draining lymph nodes, Cancer Res, 47, 1740 Robinson, 1977, Regional lymphatic drainage in primarymalignant melanoma of the trunk determined by colloidal gold scanning, Surg Forum, 28, 147 Wong, 1991, Lymphatic drainage of skin to a sentinel lymph node in a feline model, Ann Surg, 214, 637, 10.1097/00000658-199111000-00015 Morton, 1992, Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch Surg, 127, 392, 10.1001/archsurg.1992.01420040034005 Reintgen, 1996, More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques, Curr Opin Oncol, 8, 152, 10.1097/00001622-199603000-00013 Leong, 1997, Optimal selective sentinel lymph node dissection in primary malignant melanoma, Arch Surg, 132, 666, 10.1001/archsurg.1997.01430300108021 Lingam, 1997, Intraoperative identification of sentinel lymph node in patients with malignant melanoma, Br J Cancer, 75, 1505, 10.1038/bjc.1997.257 Nieweg, 1997, Lymphatic mapping and selective lymphadenectomy for melanoma: Not yet standard therapy, Eur J Surg Oncol, 23, 397, 10.1016/S0748-7983(97)93717-3 Ross, 1997, Lymphatic mapping and sentinel node biopsy for early stage melanoma: How we do it at the M.D. Anderson Cancer Center, J Surg Oncol, 66, 273, 10.1002/(SICI)1096-9098(199712)66:4<273::AID-JSO11>3.0.CO;2-1 Bostick, 1997, Intraoperative lymphatic mapping for early-stage melanoma of the head and neck, Am J Surg, 174, 536, 10.1016/S0002-9610(97)00150-5 Nathanson, 1996, Sentinel lymph node uptake of two different technetium-labeled radiocolloids, Ann Surg Oncol, 4, 104, 10.1007/BF02303791 Carson, 1996, Nodal nevi and cutaneous melanomas, Am J Surg Pathol, 20, 834, 10.1097/00000478-199607000-00006 Cochran, 1997